|
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Sep 8, 2026--Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, …
more
9/8/26
|
|
HUDSON, Mass. and YOKNEAM ILLIT, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a …
more
Lifeward Ltd.
|
9/8/26
|
|
Boston, Massachusetts, Sept. 08, 2026 (GLOBE NEWSWIRE) -- HYCU, Inc., the #1 AI Resilience company, today announced the general availability of HYCU R-Cloud for Azure DevOps, purpose-built data …
more
HYCU, Inc.
|
9/8/26
|
|
AUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none …
more
BioMedWire
|
9/8/26
|
|
BRADENTON, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Recreatives Industries, Inc. (OTC: RECX) (“Recreatives” or the “Company”), manufacturer of MAX six-wheel-drive amphibious all-terrain …
more
Recreatives Industries, Inc.
|
9/8/26
|
|
NEW YORK--(BUSINESS WIRE)--Sep 8, 2026--Forus, the AI network accelerating medicine, today announced $150 million in Series C financing at a $3 billion valuation, tripling its valuation just months …
more
9/8/26
|
|
CHICAGO--(BUSINESS WIRE)--Sep 8, 2026--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that it will now present at …
more
9/8/26
|
|
NEW YORK--(BUSINESS WIRE)--Sep 8, 2026--Tamboran Resources Corporation Chief Executive Officer, Mr. Todd Abbott, said:This press release features multimedia. View the full release here: …
more
9/8/26
|
|
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Sep 8, 2026--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Cyclophosphamide for …
more
9/8/26
|
|
PANAMA CITY, Panama & NEW YORK--(BUSINESS WIRE)--Sep 8, 2026--Hamilton Reserve Bank, the largest global bank in the Caribbean region with offices worldwide and US $25+ billion in custodial assets …
more
9/8/26
|
|
- Data from a pooled dose group of participants initially enrolled in the multiple ascending dose portion of the trial to be compared against a matched natural history cohort -- Dyne also intends to …
more
Dyne Therapeutics, Inc.
|
9/8/26
|
|
WILMINGTON, Del.--(BUSINESS WIRE)--Sep 8, 2026--Full results from the positive Phase III OBERON and TITANIA trials showed that tozorakimab is the first biologic to demonstrate statistically …
more
9/8/26
|
|
Colombia is the third Latin American market in which Cellgenic has recently announced local commercial arrangements. Activity remains subject to applicable Colombian law and the terms of local …
more
9/8/26
|
|
WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a …
more
Zenas BioPharma
|
9/8/26
|
|
- FDA Agrees to Reduced Sample Size for the Global 4WARD Phase 3 Chronic Neutropenia Trial -- Expect Completion of Enrollment by Year-End 2026 and Topline Data in H1 2028 -BOSTON, Sept. 08, 2026 …
more
X4 Pharmaceuticals
|
9/8/26
|
|
Two abstracts selected for oral presentations, highlighting investigational CAR-NK cell therapy’s clinical activity in idiopathic inflammatory myopathy and overall safety profileThird abstract …
more
Nkarta, Inc.
|
9/8/26
|
|
Live performances will take place at 2:00 PM and 3:00 PM on September 12th and 13th.BANFF, AB / ACCESS Newswire / September 8, 2026 / Banff Sunshine Village is honoured to welcome the Stoney Nakoda …
more
9/8/26
|
|
AWM and China Tourism Group launch Eastern Swell DynamicsSOLANA BEACH, CA / ACCESS Newswire / September 8, 2026 / American Wave Machines is pleased to announce the formation of Eastern Swell …
more
9/8/26
|
|
SAN FRANCISCO--(BUSINESS WIRE)--Sep 8, 2026--Rohati Capital (“Rohati”), a global venture platform built by former Amazon operators, today announced the oversubscribed close of its inaugural fund, …
more
9/8/26
|
|
NEW YORK--(BUSINESS WIRE)--Sep 8, 2026--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics …
more
9/8/26
|